Evidence map›Paper›PMID 42012353›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Electronic Clinical Quality Measures of Antibiotic Use in Hospitalized Adults With Uncomplicated Community-Acquired Pneumonia.

Andrea T White, Matthew Bidwell Goetz, Makoto Jones, Melinda M Neuhauser, Claire Ciarkowski, David Ratz, Ashwin Gupta, Lindsay A Petty, Tejal N Gandhi, Mingyuan Zhang and 6 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Andrea T WhiteDivision of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-7775-5696
Matthew Bidwell GoetzInfectious Diseases Section, VA Greater Los Angeles Healthcare System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.ORCID 0000-0003-4542-992X
Makoto JonesMedicine Service, Infectious Diseases Section, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.ORCID 0000-0001-5580-6739
Melinda M NeuhauserDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Claire CiarkowskiDivision of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-7057-0728
David RatzCenter for Clinical Management Research, Veterans Affairs Ann Arbor Health System, Ann Arbor, Michigan, USA.
Ashwin GuptaDivision of Hospital Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Lindsay A PettyDivision of Infectious Diseases, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0002-8731-105X
Tejal N GandhiDivision of Infectious Diseases, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Mingyuan ZhangData Science Services, University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0002-9837-4187
Brittany KentDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Chaorong WuDivision of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0002-1569-0978
Jennifer K HorowitzDivision of Hospital Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0002-2545-0636
Scott A FlandersDivision of Hospital Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Arjun SrinivasanDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Valerie M VaughnDivision of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0003-4362-7842

Funding

AHRQ HHS K08 HS026530AHRQ HHS K08HS026530Blue Care NetworkBlue Cross and Blue Shield of MichiganJG CDC HHS 289940
6 · The paper itself

Abstract

backgroundCommunity-acquired pneumonia (CAP) is the top indication for inpatient antibiotic use and overuse. We describe the development of 2 electronic clinical quality measures (eCQMs) assessing the percentage of hospitalized patients with uncomplicated CAP who had unsupported antibiotic duration beyond 5 days and empiric antibiotics targeting methicillin-resistant Staphylococcus aureus and/or Pseudomonas aeruginosa.

methodsBoth eCQMs were developed based on clinical guidelines, literature, and expert feedback and then specified electronically. The eCQMs were applied to patient data from 2 academic medical centers and 109 Department of Veterans Affairs (VA) healthcare systems to evaluate importance, reliability, validity, and feasibility, as defined by the Centers for Medicare and Medicaid Services.

resultsAcross all hospitals, the mean percentage of eligible patients with unsupported excess duration and inappropriate empiric antibiotic use ranged from 40% to 55% and from 17% to 56%, respectively. Within the VA cohort, reliability (median [first-tenth decile, n]) for duration and empiric eCQMs was high: 93% (63%-97%, 28 238) and 91% (63%-96%, 47 034), respectively. When compared to chart review at 1 academic hospital, both eCQMs had high sensitivity (96%, both) and specificity (92% and 93% for duration and empiric eCQMs, respectively). Feasibility was maximized by using only data elements in structured electronic health record fields. Some technically complex elements (eg, clinical stability) were retained for face validity.

conclusionsTwo eCQMs identifying unsupported excess antibiotic duration and inappropriately broad empiric antibiotic use in patients with uncomplicated CAP had high importance, reliability, validity, and feasibility. These eCQMs could be benchmarked to assist antibiotic stewardship programs in understanding and improving their antibiotic use.

Indexed as

Anti-Bacterial AgentsCommunity-Acquired PneumoniaDrug UtilizationAgedAged, 80 and overAntimicrobial StewardshipCommunity-Acquired InfectionsElectronic Health RecordsFemaleHospitalizationHumansMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedPseudomonas aeruginosaReproducibility of ResultsAnti-Bacterial Agentsantibiotic durationantimicrobial stewardshipempiric antibiotic therapypatient safety measures

Identifiers

PMID42012353
PMCPMC13537145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.